nodes	percent_of_prediction	percent_of_DWPC	metapath
Silodosin—ABCB1—epilepsy syndrome	0.148	1	CbGaD
Silodosin—UGT2B7—Carbamazepine—epilepsy syndrome	0.114	0.205	CbGbCtD
Silodosin—UGT2B7—Valproic Acid—epilepsy syndrome	0.0679	0.122	CbGbCtD
Silodosin—ABCB1—Levetiracetam—epilepsy syndrome	0.0339	0.061	CbGbCtD
Silodosin—ABCB1—Clobazam—epilepsy syndrome	0.0235	0.0423	CbGbCtD
Silodosin—ABCB1—Lamotrigine—epilepsy syndrome	0.0226	0.0407	CbGbCtD
Silodosin—ABCB1—Carbamazepine—epilepsy syndrome	0.0195	0.0351	CbGbCtD
Silodosin—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0186	0.0334	CbGbCtD
Silodosin—ABCB1—Phenytoin—epilepsy syndrome	0.0175	0.0314	CbGbCtD
Silodosin—CYP3A4—Felbamate—epilepsy syndrome	0.0173	0.0311	CbGbCtD
Silodosin—CYP3A4—Trimethadione—epilepsy syndrome	0.0173	0.0311	CbGbCtD
Silodosin—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0163	0.0292	CbGbCtD
Silodosin—ABCB1—Phenobarbital—epilepsy syndrome	0.0156	0.028	CbGbCtD
Silodosin—ABCB1—Midazolam—epilepsy syndrome	0.0154	0.0276	CbGbCtD
Silodosin—ABCB1—Diazepam—epilepsy syndrome	0.0148	0.0266	CbGbCtD
Silodosin—CYP3A4—Clonazepam—epilepsy syndrome	0.0147	0.0264	CbGbCtD
Silodosin—CYP3A4—Clobazam—epilepsy syndrome	0.0141	0.0253	CbGbCtD
Silodosin—CYP3A4—Rufinamide—epilepsy syndrome	0.012	0.0216	CbGbCtD
Silodosin—CYP3A4—Carbamazepine—epilepsy syndrome	0.0117	0.021	CbGbCtD
Silodosin—CYP3A4—Primidone—epilepsy syndrome	0.0109	0.0196	CbGbCtD
Silodosin—CYP3A4—Phenytoin—epilepsy syndrome	0.0105	0.0188	CbGbCtD
Silodosin—CYP3A4—Propofol—epilepsy syndrome	0.00977	0.0176	CbGbCtD
Silodosin—CYP3A4—Acetazolamide—epilepsy syndrome	0.00933	0.0168	CbGbCtD
Silodosin—CYP3A4—Phenobarbital—epilepsy syndrome	0.00933	0.0168	CbGbCtD
Silodosin—CYP3A4—Midazolam—epilepsy syndrome	0.0092	0.0166	CbGbCtD
Silodosin—CYP3A4—Diazepam—epilepsy syndrome	0.00885	0.0159	CbGbCtD
Silodosin—CYP3A4—Zonisamide—epilepsy syndrome	0.00864	0.0155	CbGbCtD
Silodosin—CYP3A4—Valproic Acid—epilepsy syndrome	0.00698	0.0125	CbGbCtD
Silodosin—CYP3A4—Topiramate—epilepsy syndrome	0.00629	0.0113	CbGbCtD
Silodosin—Tamsulosin—HTR7—epilepsy syndrome	0.00152	0.432	CrCbGaD
Silodosin—Tamsulosin—ADRA2A—epilepsy syndrome	0.0013	0.37	CrCbGaD
Silodosin—Tamsulosin—CYP2D6—epilepsy syndrome	0.000698	0.198	CrCbGaD
Silodosin—Mental disorder—Valproic Acid—epilepsy syndrome	0.000218	0.00113	CcSEcCtD
Silodosin—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	0.000218	0.00113	CcSEcCtD
Silodosin—Gastrointestinal pain—Diazepam—epilepsy syndrome	0.000218	0.00113	CcSEcCtD
Silodosin—Hepatobiliary disease—Gabapentin—epilepsy syndrome	0.000218	0.00113	CcSEcCtD
Silodosin—Tachycardia—Lamotrigine—epilepsy syndrome	0.000217	0.00112	CcSEcCtD
Silodosin—Insomnia—Oxcarbazepine—epilepsy syndrome	0.000217	0.00112	CcSEcCtD
Silodosin—Sinusitis—Gabapentin—epilepsy syndrome	0.000216	0.00112	CcSEcCtD
Silodosin—Hypotension—Carbamazepine—epilepsy syndrome	0.000215	0.00111	CcSEcCtD
Silodosin—Urticaria—Vigabatrin—epilepsy syndrome	0.000215	0.00111	CcSEcCtD
Silodosin—Abdominal pain—Vigabatrin—epilepsy syndrome	0.000214	0.00111	CcSEcCtD
Silodosin—Nausea—Clobazam—epilepsy syndrome	0.000214	0.0011	CcSEcCtD
Silodosin—Asthenia—Propofol—epilepsy syndrome	0.000214	0.0011	CcSEcCtD
Silodosin—Dizziness—Acetazolamide—epilepsy syndrome	0.000212	0.0011	CcSEcCtD
Silodosin—Urticaria—Diazepam—epilepsy syndrome	0.000212	0.00109	CcSEcCtD
Silodosin—Gastrointestinal pain—Felbamate—epilepsy syndrome	0.000211	0.00109	CcSEcCtD
Silodosin—Pruritus—Propofol—epilepsy syndrome	0.000211	0.00109	CcSEcCtD
Silodosin—Abdominal pain—Diazepam—epilepsy syndrome	0.000211	0.00109	CcSEcCtD
Silodosin—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	0.00021	0.00109	CcSEcCtD
Silodosin—Cardiac disorder—Pregabalin—epilepsy syndrome	0.000209	0.00108	CcSEcCtD
Silodosin—Asthenia—Midazolam—epilepsy syndrome	0.000209	0.00108	CcSEcCtD
Silodosin—Insomnia—Carbamazepine—epilepsy syndrome	0.000209	0.00108	CcSEcCtD
Silodosin—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	0.000209	0.00108	CcSEcCtD
Silodosin—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	0.000207	0.00107	CcSEcCtD
Silodosin—Gastrointestinal pain—Zonisamide—epilepsy syndrome	0.000206	0.00107	CcSEcCtD
Silodosin—Asthenia—Levetiracetam—epilepsy syndrome	0.000206	0.00107	CcSEcCtD
Silodosin—Pruritus—Midazolam—epilepsy syndrome	0.000206	0.00107	CcSEcCtD
Silodosin—Urticaria—Felbamate—epilepsy syndrome	0.000205	0.00106	CcSEcCtD
Silodosin—Angiopathy—Pregabalin—epilepsy syndrome	0.000204	0.00106	CcSEcCtD
Silodosin—Abdominal pain—Felbamate—epilepsy syndrome	0.000204	0.00105	CcSEcCtD
Silodosin—Diarrhoea—Propofol—epilepsy syndrome	0.000204	0.00105	CcSEcCtD
Silodosin—Immune system disorder—Pregabalin—epilepsy syndrome	0.000204	0.00105	CcSEcCtD
Silodosin—Pruritus—Levetiracetam—epilepsy syndrome	0.000203	0.00105	CcSEcCtD
Silodosin—Mediastinal disorder—Pregabalin—epilepsy syndrome	0.000203	0.00105	CcSEcCtD
Silodosin—Insomnia—Lamotrigine—epilepsy syndrome	0.000202	0.00104	CcSEcCtD
Silodosin—Headache—Acetazolamide—epilepsy syndrome	0.000201	0.00104	CcSEcCtD
Silodosin—Urticaria—Zonisamide—epilepsy syndrome	0.0002	0.00104	CcSEcCtD
Silodosin—Erectile dysfunction—Topiramate—epilepsy syndrome	0.0002	0.00103	CcSEcCtD
Silodosin—Abdominal pain—Zonisamide—epilepsy syndrome	0.000199	0.00103	CcSEcCtD
Silodosin—Asthenia—Fosphenytoin—epilepsy syndrome	0.000199	0.00103	CcSEcCtD
Silodosin—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000199	0.00103	CcSEcCtD
Silodosin—Gastrointestinal pain—Clonazepam—epilepsy syndrome	0.000199	0.00103	CcSEcCtD
Silodosin—Mental disorder—Pregabalin—epilepsy syndrome	0.000197	0.00102	CcSEcCtD
Silodosin—Dizziness—Propofol—epilepsy syndrome	0.000197	0.00102	CcSEcCtD
Silodosin—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000197	0.00102	CcSEcCtD
Silodosin—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	0.000196	0.00102	CcSEcCtD
Silodosin—Pruritus—Fosphenytoin—epilepsy syndrome	0.000196	0.00102	CcSEcCtD
Silodosin—Asthenia—Vigabatrin—epilepsy syndrome	0.000194	0.001	CcSEcCtD
Silodosin—Urticaria—Clonazepam—epilepsy syndrome	0.000193	0.000999	CcSEcCtD
Silodosin—Dizziness—Midazolam—epilepsy syndrome	0.000193	0.000996	CcSEcCtD
Silodosin—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000192	0.000995	CcSEcCtD
Silodosin—Abdominal pain—Clonazepam—epilepsy syndrome	0.000192	0.000994	CcSEcCtD
Silodosin—Urticaria—Phenytoin—epilepsy syndrome	0.000192	0.000992	CcSEcCtD
Silodosin—Cardiac disorder—Gabapentin—epilepsy syndrome	0.000192	0.000991	CcSEcCtD
Silodosin—Palpitations—Valproic Acid—epilepsy syndrome	0.000192	0.000991	CcSEcCtD
Silodosin—Pruritus—Vigabatrin—epilepsy syndrome	0.000191	0.00099	CcSEcCtD
Silodosin—Asthenia—Diazepam—epilepsy syndrome	0.000191	0.000988	CcSEcCtD
Silodosin—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000191	0.000987	CcSEcCtD
Silodosin—Nausea—Acetazolamide—epilepsy syndrome	0.00019	0.000984	CcSEcCtD
Silodosin—Dizziness—Levetiracetam—epilepsy syndrome	0.00019	0.000983	CcSEcCtD
Silodosin—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.00019	0.000982	CcSEcCtD
Silodosin—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.00019	0.000982	CcSEcCtD
Silodosin—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000189	0.000975	CcSEcCtD
Silodosin—Pruritus—Diazepam—epilepsy syndrome	0.000188	0.000974	CcSEcCtD
Silodosin—Rash—Propofol—epilepsy syndrome	0.000188	0.00097	CcSEcCtD
Silodosin—Dermatitis—Propofol—epilepsy syndrome	0.000188	0.000969	CcSEcCtD
Silodosin—Immune system disorder—Gabapentin—epilepsy syndrome	0.000187	0.000965	CcSEcCtD
Silodosin—Headache—Propofol—epilepsy syndrome	0.000186	0.000964	CcSEcCtD
Silodosin—Mediastinal disorder—Gabapentin—epilepsy syndrome	0.000186	0.000963	CcSEcCtD
Silodosin—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000185	0.000957	CcSEcCtD
Silodosin—Asthenia—Felbamate—epilepsy syndrome	0.000185	0.000956	CcSEcCtD
Silodosin—Rash—Midazolam—epilepsy syndrome	0.000184	0.000949	CcSEcCtD
Silodosin—Dizziness—Fosphenytoin—epilepsy syndrome	0.000184	0.000949	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.000183	0.000948	CcSEcCtD
Silodosin—Dermatitis—Midazolam—epilepsy syndrome	0.000183	0.000948	CcSEcCtD
Silodosin—Urticaria—Carbamazepine—epilepsy syndrome	0.000183	0.000947	CcSEcCtD
Silodosin—Headache—Midazolam—epilepsy syndrome	0.000182	0.000943	CcSEcCtD
Silodosin—Pruritus—Felbamate—epilepsy syndrome	0.000182	0.000943	CcSEcCtD
Silodosin—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000182	0.000942	CcSEcCtD
Silodosin—Diarrhoea—Diazepam—epilepsy syndrome	0.000182	0.000942	CcSEcCtD
Silodosin—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000182	0.000942	CcSEcCtD
Silodosin—Sinusitis—Topiramate—epilepsy syndrome	0.000182	0.000939	CcSEcCtD
Silodosin—Rash—Levetiracetam—epilepsy syndrome	0.000181	0.000937	CcSEcCtD
Silodosin—Dermatitis—Levetiracetam—epilepsy syndrome	0.000181	0.000937	CcSEcCtD
Silodosin—Asthenia—Zonisamide—epilepsy syndrome	0.000181	0.000936	CcSEcCtD
Silodosin—Mental disorder—Gabapentin—epilepsy syndrome	0.000181	0.000936	CcSEcCtD
Silodosin—Dry mouth—Valproic Acid—epilepsy syndrome	0.000181	0.000934	CcSEcCtD
Silodosin—Headache—Levetiracetam—epilepsy syndrome	0.00018	0.000931	CcSEcCtD
Silodosin—Dizziness—Vigabatrin—epilepsy syndrome	0.000179	0.000925	CcSEcCtD
Silodosin—Pruritus—Zonisamide—epilepsy syndrome	0.000179	0.000923	CcSEcCtD
Silodosin—Urticaria—Lamotrigine—epilepsy syndrome	0.000177	0.000915	CcSEcCtD
Silodosin—Nausea—Propofol—epilepsy syndrome	0.000177	0.000914	CcSEcCtD
Silodosin—Diarrhoea—Felbamate—epilepsy syndrome	0.000176	0.000912	CcSEcCtD
Silodosin—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000176	0.000911	CcSEcCtD
Silodosin—Dizziness—Diazepam—epilepsy syndrome	0.000176	0.000911	CcSEcCtD
Silodosin—Syncope—Pregabalin—epilepsy syndrome	0.000176	0.000909	CcSEcCtD
Silodosin—Rash—Fosphenytoin—epilepsy syndrome	0.000175	0.000905	CcSEcCtD
Silodosin—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000175	0.000904	CcSEcCtD
Silodosin—Asthenia—Clonazepam—epilepsy syndrome	0.000174	0.000902	CcSEcCtD
Silodosin—Headache—Fosphenytoin—epilepsy syndrome	0.000174	0.000899	CcSEcCtD
Silodosin—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000174	0.000898	CcSEcCtD
Silodosin—Palpitations—Pregabalin—epilepsy syndrome	0.000173	0.000896	CcSEcCtD
Silodosin—Asthenia—Phenytoin—epilepsy syndrome	0.000173	0.000896	CcSEcCtD
Silodosin—Nausea—Midazolam—epilepsy syndrome	0.000173	0.000894	CcSEcCtD
Silodosin—Tachycardia—Valproic Acid—epilepsy syndrome	0.000173	0.000894	CcSEcCtD
Silodosin—Diarrhoea—Zonisamide—epilepsy syndrome	0.000173	0.000893	CcSEcCtD
Silodosin—Loss of consciousness—Pregabalin—epilepsy syndrome	0.000172	0.000891	CcSEcCtD
Silodosin—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000172	0.000891	CcSEcCtD
Silodosin—Pruritus—Clonazepam—epilepsy syndrome	0.000172	0.00089	CcSEcCtD
Silodosin—Skin disorder—Valproic Acid—epilepsy syndrome	0.000172	0.000889	CcSEcCtD
Silodosin—Pruritus—Phenytoin—epilepsy syndrome	0.000171	0.000884	CcSEcCtD
Silodosin—Nausea—Levetiracetam—epilepsy syndrome	0.000171	0.000883	CcSEcCtD
Silodosin—Rash—Vigabatrin—epilepsy syndrome	0.000171	0.000882	CcSEcCtD
Silodosin—Dizziness—Felbamate—epilepsy syndrome	0.00017	0.000881	CcSEcCtD
Silodosin—Dermatitis—Vigabatrin—epilepsy syndrome	0.00017	0.000881	CcSEcCtD
Silodosin—Pruritus—Oxcarbazepine—epilepsy syndrome	0.00017	0.000879	CcSEcCtD
Silodosin—Headache—Vigabatrin—epilepsy syndrome	0.000169	0.000876	CcSEcCtD
Silodosin—Rash—Diazepam—epilepsy syndrome	0.000168	0.000868	CcSEcCtD
Silodosin—Dermatitis—Diazepam—epilepsy syndrome	0.000168	0.000867	CcSEcCtD
Silodosin—Dizziness—Zonisamide—epilepsy syndrome	0.000167	0.000863	CcSEcCtD
Silodosin—Headache—Diazepam—epilepsy syndrome	0.000167	0.000863	CcSEcCtD
Silodosin—Diarrhoea—Clonazepam—epilepsy syndrome	0.000166	0.00086	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000166	0.000857	CcSEcCtD
Silodosin—Hypotension—Valproic Acid—epilepsy syndrome	0.000165	0.000856	CcSEcCtD
Silodosin—Asthenia—Carbamazepine—epilepsy syndrome	0.000165	0.000855	CcSEcCtD
Silodosin—Diarrhoea—Phenytoin—epilepsy syndrome	0.000165	0.000855	CcSEcCtD
Silodosin—Nausea—Fosphenytoin—epilepsy syndrome	0.000165	0.000852	CcSEcCtD
Silodosin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000164	0.00085	CcSEcCtD
Silodosin—Dry mouth—Pregabalin—epilepsy syndrome	0.000163	0.000844	CcSEcCtD
Silodosin—Pruritus—Carbamazepine—epilepsy syndrome	0.000163	0.000843	CcSEcCtD
Silodosin—Rash—Felbamate—epilepsy syndrome	0.000163	0.00084	CcSEcCtD
Silodosin—Dermatitis—Felbamate—epilepsy syndrome	0.000162	0.00084	CcSEcCtD
Silodosin—Headache—Felbamate—epilepsy syndrome	0.000161	0.000835	CcSEcCtD
Silodosin—Cardiac disorder—Topiramate—epilepsy syndrome	0.000161	0.000834	CcSEcCtD
Silodosin—Syncope—Gabapentin—epilepsy syndrome	0.000161	0.000834	CcSEcCtD
Silodosin—Dizziness—Clonazepam—epilepsy syndrome	0.000161	0.000831	CcSEcCtD
Silodosin—Nausea—Vigabatrin—epilepsy syndrome	0.000161	0.000831	CcSEcCtD
Silodosin—Insomnia—Valproic Acid—epilepsy syndrome	0.00016	0.000828	CcSEcCtD
Silodosin—Asthenia—Lamotrigine—epilepsy syndrome	0.00016	0.000827	CcSEcCtD
Silodosin—Dizziness—Phenytoin—epilepsy syndrome	0.00016	0.000826	CcSEcCtD
Silodosin—Rash—Zonisamide—epilepsy syndrome	0.000159	0.000823	CcSEcCtD
Silodosin—Palpitations—Gabapentin—epilepsy syndrome	0.000159	0.000822	CcSEcCtD
Silodosin—Dermatitis—Zonisamide—epilepsy syndrome	0.000159	0.000822	CcSEcCtD
Silodosin—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000159	0.000822	CcSEcCtD
Silodosin—Nausea—Diazepam—epilepsy syndrome	0.000158	0.000818	CcSEcCtD
Silodosin—Loss of consciousness—Gabapentin—epilepsy syndrome	0.000158	0.000817	CcSEcCtD
Silodosin—Headache—Zonisamide—epilepsy syndrome	0.000158	0.000817	CcSEcCtD
Silodosin—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000158	0.000816	CcSEcCtD
Silodosin—Angiopathy—Topiramate—epilepsy syndrome	0.000158	0.000815	CcSEcCtD
Silodosin—Pruritus—Lamotrigine—epilepsy syndrome	0.000158	0.000815	CcSEcCtD
Silodosin—Shock—Pregabalin—epilepsy syndrome	0.000158	0.000814	CcSEcCtD
Silodosin—Immune system disorder—Topiramate—epilepsy syndrome	0.000157	0.000812	CcSEcCtD
Silodosin—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000157	0.000812	CcSEcCtD
Silodosin—Mediastinal disorder—Topiramate—epilepsy syndrome	0.000157	0.00081	CcSEcCtD
Silodosin—Tachycardia—Pregabalin—epilepsy syndrome	0.000156	0.000808	CcSEcCtD
Silodosin—Skin disorder—Pregabalin—epilepsy syndrome	0.000156	0.000804	CcSEcCtD
Silodosin—Rash—Clonazepam—epilepsy syndrome	0.000153	0.000793	CcSEcCtD
Silodosin—Dermatitis—Clonazepam—epilepsy syndrome	0.000153	0.000792	CcSEcCtD
Silodosin—Nausea—Felbamate—epilepsy syndrome	0.000153	0.000792	CcSEcCtD
Silodosin—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000153	0.00079	CcSEcCtD
Silodosin—Dizziness—Carbamazepine—epilepsy syndrome	0.000152	0.000788	CcSEcCtD
Silodosin—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000152	0.000788	CcSEcCtD
Silodosin—Headache—Clonazepam—epilepsy syndrome	0.000152	0.000788	CcSEcCtD
Silodosin—Rash—Phenytoin—epilepsy syndrome	0.000152	0.000787	CcSEcCtD
Silodosin—Mental disorder—Topiramate—epilepsy syndrome	0.000152	0.000787	CcSEcCtD
Silodosin—Dermatitis—Phenytoin—epilepsy syndrome	0.000152	0.000787	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000152	0.000786	CcSEcCtD
Silodosin—Rash—Oxcarbazepine—epilepsy syndrome	0.000152	0.000783	CcSEcCtD
Silodosin—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000151	0.000783	CcSEcCtD
Silodosin—Headache—Phenytoin—epilepsy syndrome	0.000151	0.000782	CcSEcCtD
Silodosin—Headache—Oxcarbazepine—epilepsy syndrome	0.000151	0.000778	CcSEcCtD
Silodosin—Nausea—Zonisamide—epilepsy syndrome	0.00015	0.000775	CcSEcCtD
Silodosin—Dry mouth—Gabapentin—epilepsy syndrome	0.00015	0.000774	CcSEcCtD
Silodosin—Hypotension—Pregabalin—epilepsy syndrome	0.00015	0.000773	CcSEcCtD
Silodosin—Dizziness—Lamotrigine—epilepsy syndrome	0.000147	0.000762	CcSEcCtD
Silodosin—Rash—Carbamazepine—epilepsy syndrome	0.000145	0.000752	CcSEcCtD
Silodosin—Dermatitis—Carbamazepine—epilepsy syndrome	0.000145	0.000751	CcSEcCtD
Silodosin—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000145	0.000749	CcSEcCtD
Silodosin—Insomnia—Pregabalin—epilepsy syndrome	0.000145	0.000749	CcSEcCtD
Silodosin—Nausea—Clonazepam—epilepsy syndrome	0.000144	0.000747	CcSEcCtD
Silodosin—Headache—Carbamazepine—epilepsy syndrome	0.000144	0.000747	CcSEcCtD
Silodosin—Shock—Gabapentin—epilepsy syndrome	0.000144	0.000747	CcSEcCtD
Silodosin—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000144	0.000744	CcSEcCtD
Silodosin—Nausea—Phenytoin—epilepsy syndrome	0.000143	0.000742	CcSEcCtD
Silodosin—Tachycardia—Gabapentin—epilepsy syndrome	0.000143	0.000741	CcSEcCtD
Silodosin—Nausea—Oxcarbazepine—epilepsy syndrome	0.000143	0.000738	CcSEcCtD
Silodosin—Skin disorder—Gabapentin—epilepsy syndrome	0.000143	0.000737	CcSEcCtD
Silodosin—Urticaria—Valproic Acid—epilepsy syndrome	0.000141	0.000727	CcSEcCtD
Silodosin—Rash—Lamotrigine—epilepsy syndrome	0.000141	0.000726	CcSEcCtD
Silodosin—Dermatitis—Lamotrigine—epilepsy syndrome	0.00014	0.000726	CcSEcCtD
Silodosin—Abdominal pain—Valproic Acid—epilepsy syndrome	0.00014	0.000724	CcSEcCtD
Silodosin—Headache—Lamotrigine—epilepsy syndrome	0.00014	0.000722	CcSEcCtD
Silodosin—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000138	0.000715	CcSEcCtD
Silodosin—Hypotension—Gabapentin—epilepsy syndrome	0.000137	0.000709	CcSEcCtD
Silodosin—Nausea—Carbamazepine—epilepsy syndrome	0.000137	0.000708	CcSEcCtD
Silodosin—Syncope—Topiramate—epilepsy syndrome	0.000136	0.000702	CcSEcCtD
Silodosin—Palpitations—Topiramate—epilepsy syndrome	0.000134	0.000691	CcSEcCtD
Silodosin—Loss of consciousness—Topiramate—epilepsy syndrome	0.000133	0.000688	CcSEcCtD
Silodosin—Insomnia—Gabapentin—epilepsy syndrome	0.000133	0.000686	CcSEcCtD
Silodosin—Nausea—Lamotrigine—epilepsy syndrome	0.000132	0.000684	CcSEcCtD
Silodosin—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000131	0.000677	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000128	0.000662	CcSEcCtD
Silodosin—Urticaria—Pregabalin—epilepsy syndrome	0.000127	0.000658	CcSEcCtD
Silodosin—Asthenia—Valproic Acid—epilepsy syndrome	0.000127	0.000657	CcSEcCtD
Silodosin—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000127	0.000655	CcSEcCtD
Silodosin—Abdominal pain—Pregabalin—epilepsy syndrome	0.000127	0.000654	CcSEcCtD
Silodosin—Dry mouth—Topiramate—epilepsy syndrome	0.000126	0.000651	CcSEcCtD
Silodosin—Pruritus—Valproic Acid—epilepsy syndrome	0.000125	0.000648	CcSEcCtD
Silodosin—Shock—Topiramate—epilepsy syndrome	0.000122	0.000628	CcSEcCtD
Silodosin—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000121	0.000626	CcSEcCtD
Silodosin—Nervous system disorder—Topiramate—epilepsy syndrome	0.000121	0.000626	CcSEcCtD
Silodosin—Tachycardia—Topiramate—epilepsy syndrome	0.000121	0.000623	CcSEcCtD
Silodosin—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.00012	0.000621	CcSEcCtD
Silodosin—Skin disorder—Topiramate—epilepsy syndrome	0.00012	0.00062	CcSEcCtD
Silodosin—Dizziness—Valproic Acid—epilepsy syndrome	0.000117	0.000605	CcSEcCtD
Silodosin—Urticaria—Gabapentin—epilepsy syndrome	0.000117	0.000603	CcSEcCtD
Silodosin—Abdominal pain—Gabapentin—epilepsy syndrome	0.000116	0.0006	CcSEcCtD
Silodosin—Hypotension—Topiramate—epilepsy syndrome	0.000115	0.000597	CcSEcCtD
Silodosin—Asthenia—Pregabalin—epilepsy syndrome	0.000115	0.000594	CcSEcCtD
Silodosin—Pruritus—Pregabalin—epilepsy syndrome	0.000113	0.000586	CcSEcCtD
Silodosin—Insomnia—Topiramate—epilepsy syndrome	0.000112	0.000578	CcSEcCtD
Silodosin—Rash—Valproic Acid—epilepsy syndrome	0.000112	0.000577	CcSEcCtD
Silodosin—Dermatitis—Valproic Acid—epilepsy syndrome	0.000112	0.000577	CcSEcCtD
Silodosin—Headache—Valproic Acid—epilepsy syndrome	0.000111	0.000574	CcSEcCtD
Silodosin—Diarrhoea—Pregabalin—epilepsy syndrome	0.00011	0.000566	CcSEcCtD
Silodosin—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.000107	0.000551	CcSEcCtD
Silodosin—Dizziness—Pregabalin—epilepsy syndrome	0.000106	0.000547	CcSEcCtD
Silodosin—Asthenia—Gabapentin—epilepsy syndrome	0.000105	0.000545	CcSEcCtD
Silodosin—Nausea—Valproic Acid—epilepsy syndrome	0.000105	0.000544	CcSEcCtD
Silodosin—Pruritus—Gabapentin—epilepsy syndrome	0.000104	0.000537	CcSEcCtD
Silodosin—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000101	0.000522	CcSEcCtD
Silodosin—Rash—Pregabalin—epilepsy syndrome	0.000101	0.000522	CcSEcCtD
Silodosin—Dermatitis—Pregabalin—epilepsy syndrome	0.000101	0.000521	CcSEcCtD
Silodosin—Diarrhoea—Gabapentin—epilepsy syndrome	0.0001	0.000519	CcSEcCtD
Silodosin—Headache—Pregabalin—epilepsy syndrome	0.0001	0.000519	CcSEcCtD
Silodosin—Urticaria—Topiramate—epilepsy syndrome	9.81e-05	0.000507	CcSEcCtD
Silodosin—Abdominal pain—Topiramate—epilepsy syndrome	9.76e-05	0.000505	CcSEcCtD
Silodosin—Dizziness—Gabapentin—epilepsy syndrome	9.71e-05	0.000502	CcSEcCtD
Silodosin—Nausea—Pregabalin—epilepsy syndrome	9.51e-05	0.000492	CcSEcCtD
Silodosin—Rash—Gabapentin—epilepsy syndrome	9.26e-05	0.000479	CcSEcCtD
Silodosin—Dermatitis—Gabapentin—epilepsy syndrome	9.25e-05	0.000478	CcSEcCtD
Silodosin—Headache—Gabapentin—epilepsy syndrome	9.2e-05	0.000475	CcSEcCtD
Silodosin—Asthenia—Topiramate—epilepsy syndrome	8.86e-05	0.000458	CcSEcCtD
Silodosin—Pruritus—Topiramate—epilepsy syndrome	8.74e-05	0.000452	CcSEcCtD
Silodosin—Nausea—Gabapentin—epilepsy syndrome	8.72e-05	0.000451	CcSEcCtD
Silodosin—Diarrhoea—Topiramate—epilepsy syndrome	8.45e-05	0.000437	CcSEcCtD
Silodosin—Dizziness—Topiramate—epilepsy syndrome	8.17e-05	0.000422	CcSEcCtD
Silodosin—Rash—Topiramate—epilepsy syndrome	7.79e-05	0.000403	CcSEcCtD
Silodosin—Dermatitis—Topiramate—epilepsy syndrome	7.78e-05	0.000402	CcSEcCtD
Silodosin—Headache—Topiramate—epilepsy syndrome	7.74e-05	0.0004	CcSEcCtD
Silodosin—Nausea—Topiramate—epilepsy syndrome	7.34e-05	0.000379	CcSEcCtD
Silodosin—ADRA1A—hindbrain—epilepsy syndrome	3.63e-05	0.0849	CbGeAlD
Silodosin—ADRA1D—forebrain—epilepsy syndrome	3.5e-05	0.0818	CbGeAlD
Silodosin—ADRA1D—telencephalon—epilepsy syndrome	3.21e-05	0.0752	CbGeAlD
Silodosin—ADRA1A—brainstem—epilepsy syndrome	2.08e-05	0.0487	CbGeAlD
Silodosin—ADRA1B—head—epilepsy syndrome	2.05e-05	0.0479	CbGeAlD
Silodosin—ADRA1A—forebrain—epilepsy syndrome	2.01e-05	0.047	CbGeAlD
Silodosin—ADRA1D—head—epilepsy syndrome	2e-05	0.0468	CbGeAlD
Silodosin—ADRA1B—nervous system—epilepsy syndrome	1.94e-05	0.0454	CbGeAlD
Silodosin—ADRA1D—nervous system—epilepsy syndrome	1.9e-05	0.0444	CbGeAlD
Silodosin—ADRA1B—central nervous system—epilepsy syndrome	1.87e-05	0.0437	CbGeAlD
Silodosin—ADRA1A—telencephalon—epilepsy syndrome	1.85e-05	0.0432	CbGeAlD
Silodosin—ADRA1D—central nervous system—epilepsy syndrome	1.83e-05	0.0427	CbGeAlD
Silodosin—ADRA1B—brain—epilepsy syndrome	1.48e-05	0.0347	CbGeAlD
Silodosin—ADRA1D—brain—epilepsy syndrome	1.45e-05	0.0339	CbGeAlD
Silodosin—ADRA1A—head—epilepsy syndrome	1.15e-05	0.0269	CbGeAlD
Silodosin—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	1.13e-05	0.000115	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—AGT—epilepsy syndrome	1.12e-05	0.000114	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.12e-05	0.000114	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—JUNB—epilepsy syndrome	1.12e-05	0.000114	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CNR1—epilepsy syndrome	1.12e-05	0.000114	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PLCB1—epilepsy syndrome	1.11e-05	0.000113	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.11e-05	0.000113	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.11e-05	0.000113	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.11e-05	0.000113	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.11e-05	0.000113	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.11e-05	0.000113	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—OPRM1—epilepsy syndrome	1.11e-05	0.000113	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CCL3—epilepsy syndrome	1.11e-05	0.000113	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HSPB1—epilepsy syndrome	1.11e-05	0.000113	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CRH—epilepsy syndrome	1.11e-05	0.000113	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—OXT—epilepsy syndrome	1.11e-05	0.000113	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CXCL2—epilepsy syndrome	1.11e-05	0.000113	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.11e-05	0.000113	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—AGT—epilepsy syndrome	1.1e-05	0.000112	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—CCR5—epilepsy syndrome	1.1e-05	0.000111	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—AQP1—epilepsy syndrome	1.1e-05	0.000111	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HTR7—epilepsy syndrome	1.09e-05	0.000111	CbGpPWpGaD
Silodosin—ADRA1A—nervous system—epilepsy syndrome	1.09e-05	0.0255	CbGeAlD
Silodosin—UGT2B7—Metabolism—APOE—epilepsy syndrome	1.08e-05	0.00011	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—AKT1—epilepsy syndrome	1.08e-05	0.000109	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—HTR2A—epilepsy syndrome	1.07e-05	0.000109	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—CCR5—epilepsy syndrome	1.07e-05	0.000109	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HBEGF—epilepsy syndrome	1.06e-05	0.000108	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CCR3—epilepsy syndrome	1.05e-05	0.000107	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.05e-05	0.000107	CbGpPWpGaD
Silodosin—ADRA1A—central nervous system—epilepsy syndrome	1.05e-05	0.0245	CbGeAlD
Silodosin—ADRA1D—Signaling Pathways—AKT3—epilepsy syndrome	1.04e-05	0.000106	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.04e-05	0.000105	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TSC1—epilepsy syndrome	1.03e-05	0.000105	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PTK2B—epilepsy syndrome	1.03e-05	0.000105	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—POMC—epilepsy syndrome	1.03e-05	0.000105	CbGpPWpGaD
Silodosin—ADRA1A—cerebellum—epilepsy syndrome	1.03e-05	0.024	CbGeAlD
Silodosin—ADRA1A—Signaling Pathways—NPY—epilepsy syndrome	1.02e-05	0.000104	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ATP2A2—epilepsy syndrome	1.02e-05	0.000104	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—AGT—epilepsy syndrome	1.02e-05	0.000103	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.02e-05	0.000103	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.02e-05	0.000103	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.02e-05	0.000103	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—ADAM10—epilepsy syndrome	1.02e-05	0.000103	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—CCL2—epilepsy syndrome	1.01e-05	0.000103	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CCR2—epilepsy syndrome	1.01e-05	0.000102	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NTRK2—epilepsy syndrome	1.01e-05	0.000102	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—SST—epilepsy syndrome	1.01e-05	0.000102	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	1e-05	0.000102	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—DUSP6—epilepsy syndrome	9.97e-06	0.000101	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—AGT—epilepsy syndrome	9.97e-06	0.000101	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	9.91e-06	0.000101	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CHRM3—epilepsy syndrome	9.91e-06	0.000101	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CCL3—epilepsy syndrome	9.88e-06	0.0001	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—OXT—epilepsy syndrome	9.88e-06	0.0001	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HSPB1—epilepsy syndrome	9.88e-06	0.0001	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CRH—epilepsy syndrome	9.88e-06	0.0001	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CXCL2—epilepsy syndrome	9.88e-06	0.0001	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ADRA2A—epilepsy syndrome	9.84e-06	0.0001	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	9.81e-06	9.96e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PLAT—epilepsy syndrome	9.8e-06	9.96e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—CCR5—epilepsy syndrome	9.75e-06	9.9e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—S100B—epilepsy syndrome	9.6e-06	9.76e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—HTR2A—epilepsy syndrome	9.54e-06	9.69e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—SOCS3—epilepsy syndrome	9.51e-06	9.66e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CDC42—epilepsy syndrome	9.49e-06	9.64e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	9.47e-06	9.62e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GBE1—epilepsy syndrome	9.47e-06	9.62e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—BDKRB2—epilepsy syndrome	9.46e-06	9.61e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CXCL12—epilepsy syndrome	9.46e-06	9.61e-05	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—POMC—epilepsy syndrome	9.44e-06	9.59e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—PRKCB—epilepsy syndrome	9.41e-06	9.56e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—IL6ST—epilepsy syndrome	9.38e-06	9.52e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—JUNB—epilepsy syndrome	9.28e-06	9.43e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CNR1—epilepsy syndrome	9.28e-06	9.43e-05	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—POMC—epilepsy syndrome	9.28e-06	9.42e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PLCB1—epilepsy syndrome	9.25e-06	9.4e-05	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—PRKCB—epilepsy syndrome	9.21e-06	9.35e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—AVP—epilepsy syndrome	9.19e-06	9.33e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TSC1—epilepsy syndrome	9.19e-06	9.33e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PTK2B—epilepsy syndrome	9.19e-06	9.33e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HTR7—epilepsy syndrome	9.06e-06	9.2e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—AGT—epilepsy syndrome	9.05e-06	9.19e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SST—epilepsy syndrome	8.94e-06	9.08e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NTRK2—epilepsy syndrome	8.94e-06	9.08e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CCR2—epilepsy syndrome	8.94e-06	9.08e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	8.9e-06	9.04e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—DUSP6—epilepsy syndrome	8.86e-06	9e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HBEGF—epilepsy syndrome	8.79e-06	8.93e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ADRA2A—epilepsy syndrome	8.74e-06	8.88e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PLAT—epilepsy syndrome	8.71e-06	8.84e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HES1—epilepsy syndrome	8.69e-06	8.82e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	8.66e-06	8.8e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—AKT3—epilepsy syndrome	8.63e-06	8.77e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—POMC—epilepsy syndrome	8.58e-06	8.71e-05	CbGpPWpGaD
Silodosin—ABCB1—forebrain—epilepsy syndrome	8.51e-06	0.0199	CbGeAlD
Silodosin—UGT2B7—Metabolism—ALB—epilepsy syndrome	8.46e-06	8.59e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—FYN—epilepsy syndrome	8.45e-06	8.58e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—NT5E—epilepsy syndrome	8.44e-06	8.57e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ALAD—epilepsy syndrome	8.44e-06	8.57e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ADAM10—epilepsy syndrome	8.43e-06	8.56e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—H2AFX—epilepsy syndrome	8.42e-06	8.55e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—BDKRB2—epilepsy syndrome	8.4e-06	8.53e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CXCL12—epilepsy syndrome	8.4e-06	8.53e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MEF2C—epilepsy syndrome	8.4e-06	8.53e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—CCL2—epilepsy syndrome	8.39e-06	8.52e-05	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—POMC—epilepsy syndrome	8.39e-06	8.52e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PRKCB—epilepsy syndrome	8.36e-06	8.49e-05	CbGpPWpGaD
Silodosin—ADRA1A—brain—epilepsy syndrome	8.33e-06	0.0195	CbGeAlD
Silodosin—ADRA1A—Signaling by GPCR—IL6ST—epilepsy syndrome	8.33e-06	8.46e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CNR1—epilepsy syndrome	8.25e-06	8.38e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—JUNB—epilepsy syndrome	8.25e-06	8.38e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PLCB1—epilepsy syndrome	8.22e-06	8.35e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—YWHAZ—epilepsy syndrome	8.12e-06	8.25e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ABCG2—epilepsy syndrome	8.07e-06	8.2e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	8.05e-06	8.18e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	8.05e-06	8.18e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HTR7—epilepsy syndrome	8.05e-06	8.17e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NGF—epilepsy syndrome	8.03e-06	8.16e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—S100B—epilepsy syndrome	7.97e-06	8.1e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—SOCS3—epilepsy syndrome	7.89e-06	8.02e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	7.88e-06	8e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CDC42—epilepsy syndrome	7.87e-06	8e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	7.87e-06	7.99e-05	CbGpPWpGaD
Silodosin—ABCB1—telencephalon—epilepsy syndrome	7.82e-06	0.0183	CbGeAlD
Silodosin—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	7.82e-06	7.94e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CCR5—epilepsy syndrome	7.81e-06	7.93e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HBEGF—epilepsy syndrome	7.81e-06	7.93e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ADSL—epilepsy syndrome	7.72e-06	7.84e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—AKT3—epilepsy syndrome	7.67e-06	7.79e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HTR2A—epilepsy syndrome	7.64e-06	7.76e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—AVP—epilepsy syndrome	7.62e-06	7.74e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—POMC—epilepsy syndrome	7.62e-06	7.74e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GLUL—epilepsy syndrome	7.57e-06	7.69e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ADAM10—epilepsy syndrome	7.49e-06	7.61e-05	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	7.45e-06	7.57e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—CCL2—epilepsy syndrome	7.45e-06	7.57e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	7.43e-06	7.55e-05	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PTGS2—epilepsy syndrome	7.4e-06	7.52e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TSC2—epilepsy syndrome	7.26e-06	7.38e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—AGT—epilepsy syndrome	7.25e-06	7.37e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HES1—epilepsy syndrome	7.21e-06	7.32e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—APOE—epilepsy syndrome	7.11e-06	7.22e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—S100B—epilepsy syndrome	7.08e-06	7.19e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	7.06e-06	7.17e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SOCS3—epilepsy syndrome	7.01e-06	7.12e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—FYN—epilepsy syndrome	7.01e-06	7.12e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CDC42—epilepsy syndrome	6.99e-06	7.1e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—H2AFX—epilepsy syndrome	6.99e-06	7.1e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MEF2C—epilepsy syndrome	6.97e-06	7.08e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—KDR—epilepsy syndrome	6.96e-06	7.07e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	6.95e-06	7.06e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—AVP—epilepsy syndrome	6.77e-06	6.88e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—AQP1—epilepsy syndrome	6.75e-06	6.85e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—YWHAZ—epilepsy syndrome	6.74e-06	6.85e-05	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	6.73e-06	6.84e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	6.72e-06	6.82e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PRKCB—epilepsy syndrome	6.7e-06	6.81e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—BCHE—epilepsy syndrome	6.69e-06	6.8e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IL6ST—epilepsy syndrome	6.67e-06	6.78e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NGF—epilepsy syndrome	6.66e-06	6.77e-05	CbGpPWpGaD
Silodosin—CYP3A4—nervous system—epilepsy syndrome	6.52e-06	0.0153	CbGeAlD
Silodosin—ADRA1B—Signaling Pathways—CCR5—epilepsy syndrome	6.48e-06	6.58e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HES1—epilepsy syndrome	6.4e-06	6.5e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	6.38e-06	6.48e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HTR2A—epilepsy syndrome	6.34e-06	6.44e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PLCB1—epilepsy syndrome	6.31e-06	6.41e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—TH—epilepsy syndrome	6.29e-06	6.39e-05	CbGpPWpGaD
Silodosin—CYP3A4—central nervous system—epilepsy syndrome	6.28e-06	0.0147	CbGeAlD
Silodosin—ADRA1A—Signaling Pathways—FYN—epilepsy syndrome	6.23e-06	6.32e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—H2AFX—epilepsy syndrome	6.2e-06	6.3e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MEF2C—epilepsy syndrome	6.19e-06	6.29e-05	CbGpPWpGaD
Silodosin—ABCB1—medulla oblongata—epilepsy syndrome	6.15e-06	0.0144	CbGeAlD
Silodosin—ADRA1D—Signaling Pathways—POMC—epilepsy syndrome	6.1e-06	6.2e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	6.1e-06	6.2e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	6.1e-06	6.2e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TSC2—epilepsy syndrome	6.03e-06	6.12e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—AGT—epilepsy syndrome	6.02e-06	6.11e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—YWHAZ—epilepsy syndrome	5.99e-06	6.08e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CCL2—epilepsy syndrome	5.97e-06	6.07e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NGF—epilepsy syndrome	5.92e-06	6.01e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—APOE—epilepsy syndrome	5.9e-06	5.99e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—KDR—epilepsy syndrome	5.78e-06	5.87e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CCR5—epilepsy syndrome	5.76e-06	5.85e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HTR2A—epilepsy syndrome	5.63e-06	5.72e-05	CbGpPWpGaD
Silodosin—ABCB1—midbrain—epilepsy syndrome	5.62e-06	0.0131	CbGeAlD
Silodosin—ADRA1B—Signaling Pathways—PRKCB—epilepsy syndrome	5.56e-06	5.65e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IL6ST—epilepsy syndrome	5.54e-06	5.63e-05	CbGpPWpGaD
Silodosin—ABCB1—spinal cord—epilepsy syndrome	5.48e-06	0.0128	CbGeAlD
Silodosin—ADRA1D—Signaling Pathways—FGF2—epilepsy syndrome	5.4e-06	5.48e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TSC2—epilepsy syndrome	5.35e-06	5.44e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—AGT—epilepsy syndrome	5.35e-06	5.43e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—HMOX1—epilepsy syndrome	5.25e-06	5.33e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—APOE—epilepsy syndrome	5.24e-06	5.32e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CAT—epilepsy syndrome	5.18e-06	5.26e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—KDR—epilepsy syndrome	5.13e-06	5.21e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—POMC—epilepsy syndrome	5.07e-06	5.15e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—RELA—epilepsy syndrome	5.01e-06	5.09e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	4.97e-06	5.05e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CCL2—epilepsy syndrome	4.96e-06	5.04e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	4.94e-06	5.02e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	4.92e-06	5e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MTOR—epilepsy syndrome	4.91e-06	4.99e-05	CbGpPWpGaD
Silodosin—ABCB1—head—epilepsy syndrome	4.87e-06	0.0114	CbGeAlD
Silodosin—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	4.85e-06	4.92e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	4.82e-06	4.89e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GPX1—epilepsy syndrome	4.68e-06	4.76e-05	CbGpPWpGaD
Silodosin—ABCB1—nervous system—epilepsy syndrome	4.62e-06	0.0108	CbGeAlD
Silodosin—ADRA1D—GPCR downstream signaling—AKT1—epilepsy syndrome	4.56e-06	4.63e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CASP3—epilepsy syndrome	4.52e-06	4.59e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	4.5e-06	4.57e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—FGF2—epilepsy syndrome	4.48e-06	4.55e-05	CbGpPWpGaD
Silodosin—ABCB1—central nervous system—epilepsy syndrome	4.45e-06	0.0104	CbGeAlD
Silodosin—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	4.4e-06	4.47e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—JUN—epilepsy syndrome	4.39e-06	4.46e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	4.35e-06	4.42e-05	CbGpPWpGaD
Silodosin—ABCB1—cerebellum—epilepsy syndrome	4.35e-06	0.0102	CbGeAlD
Silodosin—ADRA1D—Signaling Pathways—MMP9—epilepsy syndrome	4.27e-06	4.34e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—RELA—epilepsy syndrome	4.16e-06	4.22e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—AKT1—epilepsy syndrome	4.14e-06	4.21e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	4.14e-06	4.2e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—BCHE—epilepsy syndrome	4.12e-06	4.19e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—AGT—epilepsy syndrome	4.11e-06	4.17e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MTOR—epilepsy syndrome	4.08e-06	4.14e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—APOE—epilepsy syndrome	4.03e-06	4.09e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	3.98e-06	4.04e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—SRC—epilepsy syndrome	3.94e-06	4e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	3.93e-06	3.99e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	3.89e-06	3.95e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—TH—epilepsy syndrome	3.88e-06	3.94e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—VEGFA—epilepsy syndrome	3.84e-06	3.9e-05	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—AKT1—epilepsy syndrome	3.79e-06	3.85e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CASP3—epilepsy syndrome	3.75e-06	3.81e-05	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—AKT1—epilepsy syndrome	3.72e-06	3.78e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	3.69e-06	3.75e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—JUN—epilepsy syndrome	3.64e-06	3.7e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	3.62e-06	3.68e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MMP9—epilepsy syndrome	3.54e-06	3.6e-05	CbGpPWpGaD
Silodosin—ABCB1—brain—epilepsy syndrome	3.53e-06	0.00826	CbGeAlD
Silodosin—ABCB1—Metabolism—POMC—epilepsy syndrome	3.46e-06	3.51e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—AKT1—epilepsy syndrome	3.44e-06	3.49e-05	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	3.36e-06	3.42e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	3.33e-06	3.38e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—SRC—epilepsy syndrome	3.27e-06	3.32e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	3.24e-06	3.29e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	3.23e-06	3.29e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CAT—epilepsy syndrome	3.19e-06	3.24e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—VEGFA—epilepsy syndrome	3.18e-06	3.23e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ALB—epilepsy syndrome	3.15e-06	3.2e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	3.15e-06	3.2e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	3.1e-06	3.15e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	3.05e-06	3.1e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	2.9e-06	2.95e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.89e-06	2.93e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	2.83e-06	2.87e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PTGS2—epilepsy syndrome	2.76e-06	2.8e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—AGT—epilepsy syndrome	2.53e-06	2.57e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—APOE—epilepsy syndrome	2.48e-06	2.52e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—AKT1—epilepsy syndrome	2.45e-06	2.49e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—POMC—epilepsy syndrome	2.13e-06	2.16e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—AKT1—epilepsy syndrome	2.03e-06	2.06e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.94e-06	1.97e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	1.8e-06	1.83e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.7e-06	1.73e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.39e-06	1.41e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—AKT1—epilepsy syndrome	8.54e-07	8.67e-06	CbGpPWpGaD
